Perspectives on switching oral acyclovir from prescription to over-the-counter status: report of a consensus panel

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
M A SandeL G Smith

Abstract

The proposed switching of oral acyclovir from prescription to over-the-counter (OTC) status for the 5-day episodic treatment of genital herpes was considered by a consensus panel. It was concluded that self-diagnosis/misdiagnosis, misuse, and adverse drug effects were potential problems with the OTC use of acyclovir. While acyclovir reduces asymptomatic shedding of herpes simplex virus type 2, the reduction in transmission of virus potentially resulting from increased acyclovir use was felt to be of unknown extent but likely to be of benefit overall. The availability of acyclovir would likely be improved. There were differences in opinion as to whether widespread availability of acyclovir (prescription or OTC) may speed the development of viral resistance. However, all panel members felt that granting OTC status may set an undesirable precedent for the switch from prescription to OTC use of other systemically administered antiinfective agents. The effect of this precedent, in terms of accelerating development of multidrug-resistant bacteria, was a major concern of all panel members. The consensus was that the switch of acyclovir to OTC status could not be supported.

Citations

Sep 15, 2001·The New England Journal of Medicine·E P Brass
Oct 21, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Myron J LevinJeffry J Leary
Sep 3, 1999·The Journal of Antimicrobial Chemotherapy·M J Wood
May 19, 2000·Antimicrobial Agents and Chemotherapy·R T SariskyJ J Leary
Aug 17, 2002·Antimicrobial Agents and Chemotherapy·Teresa H BaconCheryl Hodges-Savola
Jan 15, 2003·Clinical Microbiology Reviews·Teresa H BaconDavid Sutton
Apr 25, 2002·Emerging Infectious Diseases·Marc Lipsitch, Matthew H Samore
Oct 3, 1999·Journal of Obstetric, Gynecologic, and Neonatal Nursing : JOGNN·B J Snell
Oct 31, 1998·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·G Boivin
Sep 6, 2011·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Anthony CunninghamRichard Whitley
Jul 24, 2004·Internal Medicine Journal·D A R Watson
Jul 27, 2005·Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [et Al.]·Michael J Messingham, Christopher J Arpey

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Allergy & Infectious Diseases (ASM)

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Allergy & Infectious Diseases

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.